Synonyms: AEGR-733 | BMS-201038 | Juxtapid® | Lojuxta®
lomitapide is an approved drug (FDA (2012), EMA (2013))
Compound class:
Synthetic organic
Comment: Lomitapide is a lipid-lowering agent for the treatment of familial hypercholesterolemia.
View more information in the IUPHAR Pharmacology Education Project: lomitapide |
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (2012), EMA (2013)) |
IUPAC Name |
N-(2,2,2-trifluoroethyl)-9-[4-[4-[[2-[4-(trifluoromethyl)phenyl]benzoyl]amino]piperidin-1-yl]butyl]fluorene-9-carboxamide |
International Nonproprietary Names | |
INN number | INN |
9120 | lomitapide |
Synonyms |
AEGR-733 | BMS-201038 | Juxtapid® | Lojuxta® |
Database Links | |
CAS Registry No. | 82431-12-5 |
ChEBI | CHEBI:72297 |
ChEMBL Ligand | CHEMBL354541 |
DrugBank Ligand | DB08827 |
DrugCentral Ligand | 4721 |
GtoPdb PubChem SID | 178104011 |
PubChem CID | 9853053 |
Search Google for chemical match using the InChIKey | MBBCVAKAJPKAKM-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | MBBCVAKAJPKAKM |
Search PubMed clinical trials | lomitapide |
Search PubMed titles | lomitapide |
Search PubMed titles/abstracts | lomitapide |
UniChem Compound Search for chemical match using the InChIKey | MBBCVAKAJPKAKM-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | MBBCVAKAJPKAKM-UHFFFAOYSA-N |
Wikipedia | Lomitapide |